February 3rd 2025 January's FDA oncology approvals offer new treatment options for breast cancer, mantle cell lymphoma, and other malignancies.

2015年1月23日 · Inavolisib in combination with palbociclib and fulvestrant improved overall survival compared to palbociclib and fulvestrant alone in patients with PIK3CA-mutated, HR …

2025年1月29日 · Erica S. Doubleday, MS, FNP-C, BSN, RN, outlined upcoming approvals and care options for providers to expect in the breast cancer space.

In August 2023, a retrospective analysis suggest that bladder-sparing radiotherapy can yield survival outcomes that are equivalent to radical cystectomy in select patients with bladder …

Abbey Kaler, MS, APRN, FNP-C, CMSRN, demonstrated extraordinary oncology nursing by being a consistent champion of the patient’s voice.

2024年12月17日 · As 2024 comes to a close,it is fascinating to look back and see the progress that has moved the oncology field forward this year. Among these advancements is the use of …

2023年2月1日 · Each month, Oncology Nursing News® takes a look back at our most popular stories. In January 2023, data presented at the 2022 San Antonio Breast Cancer Symposium …

In April 2023, new research suggested that nurses may be able to extend the flush times for implanted vascular access devices; 4 gastrointestinal (GI) cancer specialists relayed their …

2023年3月1日 · Each month, Oncology Nursing News® takes a look back at our most popular stories.

In November 2022, HER2-directed therapies made headlines in breast cancer as did innovations to help individuals who are often overlooked in oncology care.